[go: up one dir, main page]

SE9701219D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE9701219D0
SE9701219D0 SE9701219A SE9701219A SE9701219D0 SE 9701219 D0 SE9701219 D0 SE 9701219D0 SE 9701219 A SE9701219 A SE 9701219A SE 9701219 A SE9701219 A SE 9701219A SE 9701219 D0 SE9701219 D0 SE 9701219D0
Authority
SE
Sweden
Prior art keywords
pct
date
sec
inflammatory
useful
Prior art date
Application number
SE9701219A
Other languages
English (en)
Inventor
Nicholas Kindon
Premji Meghani
Stephen Thom
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Priority to SE9701219A priority Critical patent/SE9701219D0/sv
Publication of SE9701219D0 publication Critical patent/SE9701219D0/sv
Priority to AU69354/98A priority patent/AU6935498A/en
Priority to JP54267098A priority patent/JP2001518894A/ja
Priority to EP98915086A priority patent/EP0973789A1/en
Priority to US09/068,076 priority patent/US5985849A/en
Priority to PCT/SE1998/000587 priority patent/WO1998045309A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
SE9701219A 1997-04-04 1997-04-04 New compounds SE9701219D0 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE9701219A SE9701219D0 (sv) 1997-04-04 1997-04-04 New compounds
AU69354/98A AU6935498A (en) 1997-04-04 1998-03-30 Novel phosphate compounds and their use as medicaments
JP54267098A JP2001518894A (ja) 1997-04-04 1998-03-30 新規なリン酸化合物および医薬としてのその使用
EP98915086A EP0973789A1 (en) 1997-04-04 1998-03-30 Novel phosphate compounds and their use as medicaments
US09/068,076 US5985849A (en) 1997-04-04 1998-03-30 Phosphate compounds and their use as medicaments
PCT/SE1998/000587 WO1998045309A1 (en) 1997-04-04 1998-03-30 Novel phosphate compounds and their use as medicaments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9701219A SE9701219D0 (sv) 1997-04-04 1997-04-04 New compounds

Publications (1)

Publication Number Publication Date
SE9701219D0 true SE9701219D0 (sv) 1997-04-04

Family

ID=20406419

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9701219A SE9701219D0 (sv) 1997-04-04 1997-04-04 New compounds

Country Status (6)

Country Link
US (1) US5985849A (sv)
EP (1) EP0973789A1 (sv)
JP (1) JP2001518894A (sv)
AU (1) AU6935498A (sv)
SE (1) SE9701219D0 (sv)
WO (1) WO1998045309A1 (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID29198A (id) * 1997-08-29 2001-08-09 Univ North Carolina Pemakaian uridin 5'-difosfat dan persamaannya untuk mengobati penyakit paru-paru
ES2172939T3 (es) * 1997-11-21 2002-10-01 Astrazeneca Uk Ltd Nuevos compuestos que son antagonistas de receptores acoplados a proteina g de 7-transmembrana (tm) de p2-purinoceptores.
SE521031C2 (sv) * 1999-05-05 2003-09-23 Srinivas Uppugunduri Nya specifika inhibitorer av akut och kronisk inflammation
SE9903345D0 (sv) 1999-09-17 1999-09-17 Astra Pharma Prod Novel process
AU2000236800A1 (en) * 2000-04-17 2001-10-30 Fuso Pharmaceutical Industries, Ltd. Novel calcium antagonists
US7115585B2 (en) * 2000-08-21 2006-10-03 Inspire Pharmaceuticals, Inc. Compositions for treating epithelial and retinal tissue diseases
US7109181B2 (en) * 2001-06-25 2006-09-19 Inspire Pharmaceuticals, Inc. Joint lubrication with P2Y purinergic receptor agonists
AUPS160602A0 (en) 2002-04-08 2002-05-16 University Of Queensland, The Therapeutic method
AU2003230832A1 (en) 2002-04-22 2003-11-03 Joseph F. Lawler Jr. Reagents for monitoring nuclei acid amplification and methods of using same
US7179481B2 (en) * 2002-09-19 2007-02-20 Kimberly-Clark Worldwide, Inc. Vaginal health products
ATE509632T1 (de) * 2002-10-16 2011-06-15 Promics Pty Ltd Behandlung von entzündlicher darmerkrankung
US7098189B2 (en) * 2002-12-16 2006-08-29 Kimberly-Clark Worldwide, Inc. Wound and skin care compositions
US7056889B2 (en) 2002-12-16 2006-06-06 Kimberly-Clark, Worldwide, Inc. Compounds that bind P2Y2 or P2Y1 receptors
US7485666B2 (en) * 2004-06-17 2009-02-03 Kimberly-Clark Worldwide, Inc. Vaginal health products
SE529064C2 (sv) * 2005-01-03 2007-04-24 Selectica Pharmaceuticals Ab Topiska kompositioner
HUP0600042A3 (en) * 2006-01-19 2012-12-28 Debreceni Egyetem New medical use of thiolated pyrimidine-mononucleotides and -nucleosides
EP2123285A1 (en) * 2008-05-21 2009-11-25 INSERM (Institut National de la Santé et de la Recherche Médicale) Nucleosidic phosphoantigens for use in VGAMMA9DELTA2 T cell-mediated therapy
GB0919070D0 (en) * 2009-10-30 2009-12-16 Univ East Anglia Compounds and their uses in glycosyltransferase binding assays

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3462416A (en) * 1967-01-30 1969-08-19 Upjohn Co Hydrogenated pyrimidine nucleosides and nucleotides
DE3048873A1 (de) * 1980-12-23 1982-07-15 Robugen Gmbh Pharmazeutische Fabrik Esslingen A.N., 7300 Esslingen Alkyl- und alkenylpyrimidinnucleosid-phosphonate, verfahren zur herstellung und sie enthaltende mittel
DE3048877A1 (de) * 1980-12-23 1982-07-08 Kailash Kumar Prof. Dr. 2359 Lentföhrden Gauri Pyrimidinnucleosid-phosphonate, verfahren zur herstellung und sie enthaltende mittel
FI832884L (fi) * 1982-08-17 1984-02-18 Sandoz Ag Desoxiuridinderivat, deras framstaellningsfoerfaranden och anvaendning som farmaceutiska medel
US5627165A (en) * 1990-06-13 1997-05-06 Drug Innovation & Design, Inc. Phosphorous prodrugs and therapeutic delivery systems using same
CA2150940C (en) * 1992-12-08 2007-08-21 Reid Warren Von Borstel Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
DE59404522D1 (de) * 1993-09-17 1997-12-11 Ciba Geigy Ag TTTr als Schutzgruppe in der Nukleotidsynthese

Also Published As

Publication number Publication date
WO1998045309A1 (en) 1998-10-15
US5985849A (en) 1999-11-16
EP0973789A1 (en) 2000-01-26
AU6935498A (en) 1998-10-30
JP2001518894A (ja) 2001-10-16

Similar Documents

Publication Publication Date Title
SE9701219D0 (sv) New compounds
DE69619141D1 (en) Festphasensynthese von oligonucleotid n3'-p5'-phosphoramidaten
CY1105579T1 (el) Kαρβαμιδο - υποκατεστημενες πυραζολοπυριδινες
GT200100160A (es) Derivados 4-fenil-piridina.
ATE235465T1 (de) Antiimflammatorische indolderivate
ATE311380T1 (de) Durch säuregruppen disubstitierte heteroaryl- derivate und ihre verwendung als matrix metalloproteinas inhibitoren
CY1105198T1 (el) Παραγωγα πιπepιδινης χρησιμα σαν ανταγωνιστες ccr5 για τη θepαπεια ιου ανθρωπινης ανοσοανεπαρκειας (hiv)
PE20020953A1 (es) Benzotiadiazina como inhibidores de metaloproteinasas de matriz
YU37499A (sh) Derivati arilsulfonil hidroksamske kiseline
DK0738270T3 (da) Dihydropyrazolopyrroler
AP9801174A0 (en) Cyclic sulfone derivatives.
MY148652A (en) New crystalline form of a triazolo(4,5-d)pyrimidine compound
CO5170522A1 (es) Derivados de piperidina utiles como antagonsitas de ccr5
PA8445801A1 (es) Derivados de acidos arilsulfonilaminohidroxamicos
ATE464286T1 (de) Cyclopropanderivate und ihre pharmazeutische verwendung
NZ510435A (en) Arylsulfonanilide ureas and pharmaceutical use
DE69813895D1 (de) Phenolsulfonamide als pde-iv inhibitoren und ihre therapeutische verwendung
ATE392421T1 (de) Von pyrazol abgeleitete kinaseinhibitoren und deren verwendung
ATE240328T1 (de) Substituierte azaoxindolederivate
ES2158345T3 (es) Derivados de piperazino como antagonistas de la neuroquinina.
PT1129096E (pt) Antagonistas de receptor de crf e metodos de tratamento relacionados com os mesmos
MX9702734A (es) Benzopirano y compuestos benzocondensados, su preparacion y su uso como antagonistas de leucotrieno b4 (ltb4).
CR7854A (es) Dihidrofenantridinosulfonamidas sustituidas
TR200002625T2 (tr) Vitronektin Reseptörü Antagonistleri
GT200100232A (es) Derivados de pirimidina.